Artiva Biotherapeutics In... (ARTV)
NASDAQ: ARTV
· Real-Time Price · USD
2.98
0.23 (8.36%)
At close: Aug 18, 2025, 10:40 AM
Artiva Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | n/a | n/a | 251K | 2.6M | 29.26M | 29.26M | 30M | 27.64M | 989K | 989K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | 251K | 2.6M | 29.26M | 29.26M | 30M | 27.64M | 989K | 989K |
Operating Income | -81.58M | -74.96M | -67.28M | -60.99M | -31.84M | -27.48M | -30.67M | -18.7M | -29.51M | -17.69M |
Interest Income | 7.45M | 5.89M | 4.67M | 3.08M | 1.65M | 1.65M | 2.02M | 1.44M | 1.02M | 1.02M |
Pretax Income | -68.25M | -61.53M | -55.19M | -56.87M | -28.12M | -29.45M | -32.2M | -21.3M | -32.58M | -16.72M |
Net Income | -68.25M | -61.53M | -55.19M | -56.95M | -28.2M | -29.52M | -32.27M | -21.3M | -32.58M | -16.72M |
Selling & General & Admin | 19.83M | 18.74M | 17.2M | 15.42M | 13.39M | 13.59M | 13.91M | 10.74M | 7.96M | 3.91M |
Research & Development | 61.75M | 56.23M | 50.33M | 48.17M | 47.71M | 46.64M | 50.25M | 39.1M | 26.03M | 14.77M |
Other Expenses | n/a | n/a | 147K | 147K | 147K | 116K | -84K | -84K | -84K | -53K |
Operating Expenses | 81.58M | 74.96M | 67.53M | 63.59M | 61.1M | 60.23M | 64.16M | 49.84M | 34M | 18.68M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 58.77M | 74.96M | 67.53M | 63.59M | 61.1M | 60.23M | 64.16M | 49.84M | 34M | 18.68M |
Income Tax Expense | n/a | n/a | n/a | 72K | 72K | 72K | 72K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 24.38M | 24.34M | 11.26M | 18.9M | 23.28M | 17.58M | 20.43M | 9.36M | 17.58M | 17.58M |
Shares Outstanding (Diluted) | 24.38M | 24.34M | 11.26M | 18.9M | 23.28M | 17.58M | 20.43M | 9.36M | 17.58M | 17.58M |
EPS (Basic) | -3.44 | -3.19 | -3.15 | -2.87 | -0.75 | -1.03 | -1.19 | -0.65 | -1.85 | -0.95 |
EPS (Diluted) | -3.44 | -3.19 | -3.15 | -2.87 | -0.75 | -1.03 | -1.19 | -0.65 | -1.85 | -0.95 |
EBITDA | -79.71M | -72.49M | -64.85M | -58.58M | -29.5M | -28.7M | -31.9M | -20.53M | -31.89M | -17.11M |
EBIT | -58.77M | -74.96M | -67.28M | -60.99M | -31.84M | -30.97M | -34.17M | -22.2M | -33.01M | -17.69M |
Depreciation & Amortization | 1.87M | 2.47M | 2.43M | 2.41M | 2.34M | 2.27M | 2.27M | 1.67M | 1.12M | 578K |